DK1564290T3 - Fremgangsmåde til identifikation af nucleinsyreligander i målvæv - Google Patents

Fremgangsmåde til identifikation af nucleinsyreligander i målvæv

Info

Publication number
DK1564290T3
DK1564290T3 DK04015822T DK04015822T DK1564290T3 DK 1564290 T3 DK1564290 T3 DK 1564290T3 DK 04015822 T DK04015822 T DK 04015822T DK 04015822 T DK04015822 T DK 04015822T DK 1564290 T3 DK1564290 T3 DK 1564290T3
Authority
DK
Denmark
Prior art keywords
nucleic acid
acid ligands
cells
ligands
target tissues
Prior art date
Application number
DK04015822T
Other languages
Danish (da)
English (en)
Inventor
Andrew Stephens
Daniel J Schneider
Larry Gold
Ulrich Speck
Original Assignee
Gilead Sciences Inc
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/433,126 external-priority patent/US5688935A/en
Priority claimed from US08/433,124 external-priority patent/US5750342A/en
Application filed by Gilead Sciences Inc, Bayer Schering Pharma Ag filed Critical Gilead Sciences Inc
Application granted granted Critical
Publication of DK1564290T3 publication Critical patent/DK1564290T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6811Selection methods for production or design of target specific oligonucleotides or binding molecules
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/111General methods applicable to biologically active non-coding nucleic acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/115Aptamers, i.e. nucleic acids binding a target molecule specifically and with high affinity without hybridising therewith ; Nucleic acids binding to non-nucleic acids, e.g. aptamers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/10Type of nucleic acid
    • C12N2310/16Aptamers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/30Chemical structure
    • C12N2310/32Chemical structure of the sugar
    • C12N2310/3222'-R Modification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/30Chemical structure
    • C12N2310/35Nature of the modification
    • C12N2310/351Conjugate
    • C12N2310/3517Marker; Tag
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2320/00Applications; Uses
    • C12N2320/10Applications; Uses in screening processes
    • C12N2320/13Applications; Uses in screening processes in a process of directed evolution, e.g. SELEX, acquiring a new function
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/914Hydrolases (3)
    • G01N2333/948Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96433Serine endopeptidases (3.4.21)

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK04015822T 1995-05-03 1996-05-01 Fremgangsmåde til identifikation af nucleinsyreligander i målvæv DK1564290T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/433,126 US5688935A (en) 1990-06-11 1995-05-03 Nucleic acid ligands of tissue target
US08/433,124 US5750342A (en) 1990-06-11 1995-05-03 Nucleic acid ligands of tissue target
PCT/US1996/006059 WO1996034874A1 (fr) 1995-05-03 1996-05-01 Ligands a acide nucleique pour cibles tissulaires

Publications (1)

Publication Number Publication Date
DK1564290T3 true DK1564290T3 (da) 2008-11-17

Family

ID=27029755

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04015822T DK1564290T3 (da) 1995-05-03 1996-05-01 Fremgangsmåde til identifikation af nucleinsyreligander i målvæv

Country Status (9)

Country Link
EP (3) EP0824540B1 (fr)
JP (1) JPH11504812A (fr)
AT (2) ATE276266T1 (fr)
AU (1) AU727460B2 (fr)
CA (2) CA2219106C (fr)
DE (2) DE69633386T2 (fr)
DK (1) DK1564290T3 (fr)
ES (1) ES2310695T3 (fr)
WO (1) WO1996034874A1 (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6346611B1 (en) * 1990-06-11 2002-02-12 Gilead Sciences, Inc. High affinity TGfβ nucleic acid ligands and inhibitors
US6716580B2 (en) 1990-06-11 2004-04-06 Somalogic, Inc. Method for the automated generation of nucleic acid ligands
US6127119A (en) * 1990-06-11 2000-10-03 Nexstar Pharmaceuticals, Inc. Nucleic acid ligands of tissue target
US6068829A (en) 1995-09-11 2000-05-30 The Burnham Institute Method of identifying molecules that home to a selected organ in vivo
US20070166741A1 (en) 1998-12-14 2007-07-19 Somalogic, Incorporated Multiplexed analyses of test samples
US6232287B1 (en) 1998-03-13 2001-05-15 The Burnham Institute Molecules that home to various selected organs or tissues
CA2360748A1 (fr) * 1999-01-19 2000-07-27 Larry Gold Procede et dispositif de production automatisee de ligands d'acide nucleique
US20040170955A1 (en) 2000-09-08 2004-09-02 Wadih Arap Human and mouse targeting peptides identified by phage display
US7420030B2 (en) 2000-09-08 2008-09-02 The Board Of Regents Of The University Of Texas System Aminopeptidase A (APA) targeting peptides for the treatment of cancer
US7452964B2 (en) 2001-09-07 2008-11-18 Board Of Regents, The University Of Texas System Compositions and methods of use of targeting peptides against placenta and adipose tissues
US8030465B2 (en) 2001-06-29 2011-10-04 Medimolecular Pty Ltd Nucleic acid ligands to complex targets
AU2775402A (en) * 2001-06-29 2003-01-02 Medimolecular Pty Ltd Nucleic acid ligands to complex targets
US7855054B2 (en) 2007-01-16 2010-12-21 Somalogic, Inc. Multiplexed analyses of test samples
US20110136099A1 (en) 2007-01-16 2011-06-09 Somalogic, Inc. Multiplexed Analyses of Test Samples
US8906700B2 (en) 2007-11-06 2014-12-09 Ambergen, Inc. Methods and compositions for phototransfer
EP2078751A1 (fr) * 2008-01-11 2009-07-15 Commissariat A L'energie Atomique Aptamères spécifiques générés pour la suppression de la migration cellulaire et l'invasion par des cellules cancéreuses, procédés de sélection de tels aptamères et leur utilisation
EP2159286A1 (fr) * 2008-09-01 2010-03-03 Consiglio Nazionale Delle Ricerche Procédé pour obtenir des aptamères d'oligonucléotide et utilisations associées
AU2014353102B2 (en) 2013-11-21 2019-05-16 Somalogic Operating Co., Inc. Cytidine-5-carboxamide modified nucleotide compositions and methods related thereto

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5683867A (en) 1990-06-11 1997-11-04 Nexstar Pharmaceuticals, Inc. Systematic evolution of ligands by exponential enrichment: blended SELEX
US5637459A (en) 1990-06-11 1997-06-10 Nexstar Pharmaceuticals, Inc. Systematic evolution of ligands by exponential enrichment: chimeric selex
US5496938A (en) 1990-06-11 1996-03-05 Nexstar Pharmaceuticals, Inc. Nucleic acid ligands to HIV-RT and HIV-1 rev
JP2763958B2 (ja) 1990-06-11 1998-06-11 ネクスター ファーマスーティカルズ,インコーポレイテッド 核酸リガンド
US5270163A (en) 1990-06-11 1993-12-14 University Research Corporation Methods for identifying nucleic acid ligands
US5705337A (en) 1990-06-11 1998-01-06 Nexstar Pharmaceuticals, Inc. Systematic evolution of ligands by exponential enrichment: chemi-SELEX
CA2104698A1 (fr) * 1991-02-21 1992-08-22 John J. Toole Aptameres specifiques de biomolecules et methodes de production
WO1992014842A1 (fr) * 1991-02-21 1992-09-03 Gilead Sciences, Inc. Aptameres specifiques contre la thrombine et procedes d'utilisation
US5726014A (en) * 1991-06-27 1998-03-10 Genelabs Technologies, Inc. Screening assay for the detection of DNA-binding molecules
WO1994029479A1 (fr) * 1993-06-09 1994-12-22 Pharmagenics, Inc. Oligonucleotides inhibant la fonction de protease du vih
DE69633227T2 (de) * 1995-05-03 2005-09-15 Gilead Sciences, Inc., Foster City Systematische evoultion von liganden durch exponentielle anreicherung: gewebe-selex
US20170110787A1 (en) 2015-10-14 2017-04-20 Apple Inc. Electronic Devices With Millimeter Wave Antennas And Metal Housings

Also Published As

Publication number Publication date
DE69633386T2 (de) 2005-09-22
ATE401424T1 (de) 2008-08-15
EP1564290A3 (fr) 2006-02-01
AU5720096A (en) 1996-11-21
CA2641149A1 (fr) 1996-11-07
DE69633386D1 (de) 2004-10-21
ATE276266T1 (de) 2004-10-15
CA2219106C (fr) 2008-09-23
EP0824540A1 (fr) 1998-02-25
EP1564290B1 (fr) 2008-07-16
EP0824540B1 (fr) 2004-09-15
AU727460B2 (en) 2000-12-14
ES2310695T3 (es) 2009-01-16
JPH11504812A (ja) 1999-05-11
WO1996034874A1 (fr) 1996-11-07
EP0824540A4 (fr) 2003-04-23
DE69637605D1 (de) 2008-08-28
CA2219106A1 (fr) 1996-11-07
EP1564290A2 (fr) 2005-08-17
EP2000534A3 (fr) 2009-09-02
EP2000534A2 (fr) 2008-12-10

Similar Documents

Publication Publication Date Title
DK1564290T3 (da) Fremgangsmåde til identifikation af nucleinsyreligander i målvæv
CA2219807A1 (fr) Evolution systematique des ligands par enrichissement exponentiel: procede selex pour tissus
DE69434942D1 (de) Mehrzweckreagenzsystem zur schnellen lysierung von vollblutproben
DE69915932D1 (de) Verfahren zur Bestimmung von Ziel-Nukleinsäuren
MX9100052A (es) Biblioteca(o conjunto)de bio-oligomeros al azar,un metodo de sintesis de los mismos y un metodo de uso de los mismos
ATE191513T1 (de) Verfahren zur amplifikation von nukleinsäuren
DE69128362T2 (de) Zusammensetzungen und verfahren zur identifizierung von molekülen mit biologischer wirksamkeit
DE614989T1 (de) Verfahren für in vivo Selektion von Ligandenbindende Proteine.
ATE266723T1 (de) Lösung die chaotropische mittel enthält und verwendung dieser lösung in verfahren zur isolierung von dna, rna und proteinen
DE68915202D1 (de) Verfahren zur Vermehrung und zum Nachweis von Nukleinsäuresequenzen.
DE69626832D1 (de) Blutbehandlungssysteme und methoden zur gewinnung von mononuklearen zellen
ID28623A (id) Turunan 2-amino-tiazol, proses pembuatannya, dan penggunaannya sebagai zat anti tumor
ID28971A (id) Turunan 2-ureido-tiazol, proses pembuatannya, dan penggunaannya sebagai zat anti tumor
ATE329012T1 (de) Verfahren zur gewinnung von seltenen zellen aus blutprodukten
WO1996034113A3 (fr) Procedes d'identification d'inhibiteurs de transferases de farnesyl
DE1155368T1 (de) PAGING-FäHIGER FILTERTREIBER ZUR SPEKULATIVEN IMPLEMENTIERUNG VON PLATTENSPEICHER-QUOTEN
DE69815370D1 (de) Fluoreszend-konjugaten von nukleosiden und von nukleotiden, ihrer verfahren zur herstellung und ihrer verwendungen
DE69604990D1 (de) Verfahren zur Erhöhung der Katalysatorwirksamkeit bei der Redistribution von Polycarbonat
DE59712415D1 (de) Verfahren zur amplifikation von nukleinsäure
DE69508633D1 (de) Verfahren zur stufenweise Pfropfung von Olefinpolymeren und daraus hergestellte Pfropfpolymerisate
DE69807148T2 (de) Verfahren zur Hydroformylierung von Olefininen
DE69934057D1 (de) Verfahren zur Behandlung von Alkylamino (Meth)Acrylaten
ATE293121T1 (de) Verfahren zur kombination von paralleler oligonukleotidsynthese und darstellung von oligomer-chips
DE69002747T2 (de) Verfahren zur selektiven Hydrogenolyse von Perhalogenethanen.
DE59009410D1 (de) Verfahren zum passiven Bestimmen von Zieldaten.